Correction: The inflammatory marker SIRI acts as a statistical mediator between ApoB/ApoA1 ratio and atrial fibrillation, and combined biomarkers show higher discriminative ability for the presence of atrial fibrillation than single indicators - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction: The inflammatory marker SIRI serves as a statistical mediator linking the ApoB/ApoA1 ratio to atrial fibrillation, with combined biomarkers demonstrating superior discriminative power for atrial fibrillation compared to individual markers.

  • By

  • Chenyang Zheng

  • Meixue Jia

  • Bin Ning

  • September 2, 2026

Share

Objective:

To correct the Data Availability statement in the original article regarding the inflammatory marker SIRI and its relationship with atrial fibrillation.

Approach:
  • Correction: The Data Availability statement was corrected to indicate that the article contains the study’s original contributions and that additional inquiries may be directed to the corresponding authors.
Key Findings:
  • The original Data Availability statement was incorrectly provided.
  • The corrected statement clarifies how to access the study's contributions.
Interpretation:

The correction ensures accurate communication regarding data availability related to the study.

Conclusion:

The original version of the article has been updated to reflect the correct Data Availability statement.

Sources:

Original Source(s)

Related Content